STUDY GOALS AND OBJECTIVES
This report “PHM113A Prostate Cancer: Drug Technologies, Diagnostics and Global Markets” provides an overview of the current and potential global market for prostate cancer treatments and testing technologies. The key objective is to present a comprehensive analysis of the current state of prostate cancer therapy and technology, utilization of the various therapeutic and diagnostic modalities to prevent and treat prostate cancer. The report’s focus is on prostate cancer treatment strategies such as hormone therapy, chemotherapy, radiotherapy and immunotherapy, and other treatment modalities and testing and screening methods. The report also includes an overview on prostate cancer staging, diagnostic strategies and technologies. Important trends in the field of prostate cancer research and development have been reviewed in this report, and sales forecasts by treatment and screening categories are provided from 2012 through 2017. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the prostate cancer market.
REASONS FOR DOING THIS STUDY
This study was conducted to provide detailed information regarding screening, testing and treatment options for prostate cancer. There is an increasing need for new and innovative technologies. This industry is experiencing growth. The use of new drug delivery technologies for prostate cancer has increased in the past few years. This study looks at most types of treatment strategies for the clinical management of prostate cancer.
This BCC market research report will increase the awareness of current and emerging drugs and technologies for prostate cancer, including hormone therapy, chemotherapy, radiation therapy, surgical therapy, immunotherapy and also nutrition therapy.
This report is an exhaustive study on the global prostate cancer market, with important statistics and analysis on existing drugs, and diagnostic technologies, latest trends, market structure, market size, key drug segments and trends in technology. This study contributes to the areas of market growth in prostate cancer prevention and treatment strategies from the point of view of manufacturers, product suppliers, healthcare providers and consumers of prostate cancer products and services. This study will be of interest largely to the pharmaceutical and biotechnology industries, as well as clinics, hospitals and research institutes. This report may also prove crucial for investment firms in the concerned sector. This report shows tests currently being used for prostate cancer diagnosis and prognosis, new developments, spending trends and revenue prospects for these technologies. The report provides market data for 2010 to 2017 and also covers commercial prospects for prostate cancer diagnostic assays, current tests in use and their future.
SCOPE OF THE STUDY
The scope of this study is testing, screening technology and also therapeutics markets for prostate cancer. The report also includes the regulatory environment, current technologies, new technologies, prostate cancer incidence, market projections and market share, along with latest trends and new developments.
Both primary and secondary research methodologies were used in preparing this report. Secondary sources include books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to paid and free databases. The base year of the report is 2012, with forecast data provided through 2017. Historical, base year and forecast data are provided for each market segment of this report. The report provides a comprehensive review of prostate cancer, incidence and development of the disease, drugs currently being used and diagnostic technologies. The report also reviews technological developments, product innovations/ introductions and recent strategic industry activity of major players across various product categories. Growth rates, global incidence and projections are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in R&D and current product growth, etc. Forecasts and projections were based on estimates such as the current trends, potential users, mergers and acquisitions, and market trends.
A comprehensive and exhaustive search of the literature on prostate cancer assay development and already-marketed products, global incidence and latest drug developments was conducted. These secondary sources included scientific-related journals and articles, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports and other publications. A patent search and analysis were also conducted. Some informal interviews were also conducted with experts and personnel in this area at biotech and pharmaceutical companies. Other resources included academics, technology and consulting companies.
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers, end users of products, which included pharmaceutical and biotechnical industries, research institutes, etc. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.
ABOUT THE AUTHOR
Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs from target identification, including IND enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early start-ups to fulfill operational obligations while minimizing overall operational cost and burden.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders.
- Subscribe to any of BCC Research’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.